TeiaCare is a technology for Contact-Free Continuous Monitoring (CFCM) of vital signs and activity parameters for Long-Term Care including heart, breathing and movements. It is a novel software-only technology leveraging deep learning and computer vision analytics which, coupled with off-the-shelf cameras (CCTV), provides insights and multiple Smart Alerts, Reminders and Reports for caregivers. TeiaCare is designed for post-acute hospitals’ patients and nursing homes’ residents.
Team members: 8
Founded in: 2017
Stage: Seed
Market: B2B
Headquarter: Milan, Italy
Actual Market: Italy
Looking for funding: Yes
TeiaCare is sold to hospitals and nursing homes through medical device distributors with a B2B business model with two revenue streams: 1) an upfront fee for system installation; 2) an annual subscription fee for hardware and software updates and maintenance. The concept behind TeiaCare commercialization strategy is to first release the product to the EU market, before expanding into the US and global markets. Initial target countries include Italy, Germany, UK, France and Spain.
5 facilities using TeiaCare
TeiaSigns available
First 2 facilities abroad engaged
25 facilities using TeiaCare
€600k MRR
